Pacs Group, Inc. Stock Prediction and Forecast [PACS]

AI-generated source summary

The analysis, updated November 19, 2025, rates Pacs Group, Inc. (PACS) as a Strong Buy Candidate with a score of 7.938. The stock closed at $16.83 on the last trading day, marking a 16.63% increase with a 21.36% fluctuation between its daily high of $17.10 and low of $14.09. Trading volume increased, which is a positive technical indicator. Over the past two weeks, the stock has risen by 31.7%. The 52-week high was $17.70, and the current price is 4.92% below this peak, while the all-time high was $43.92 on November 1, 2024. The 3-month trend suggests a potential increase of 13.95%, placing a target at approximately $19.18, while the 12-month analysis projects a change of -14.33%. Technical signals are mostly positive, with both short-term and long-term Moving Averages showing buy signals. The short-term average is above the long-term average, indicating a bullish trend. A buy signal from a pivot bottom point on September 10, 2025, has already resulted in a 118.29% rise, with further gains anticipated. A 3-month Moving Average Convergence Divergence (MACD) also indicates a buy signal, supported by rising volume alongside price. Support levels are identified at $15.70, $14.43, and $13.85. Weakness below these points would issue sell signals. The stock exhibits high weekly volatility at 16.07%. The price-to-earnings (P/E) ratio is 22.39. Recent news indicates PACS cleared an administrative hurdle by restating financials and releasing Q3 2025 results, which may provide short-term relief, but ongoing investor investigations and potential class-action claims filed in October introduce risk premium and volatility. Analyst ratings are mixed, with some issuing 'Buy' and 'Outperform' ratings, while others give 'Overweight' and 'Underperform'. Insider trading shows a negative 'Insider Power' (-70.803), reflecting significant insider selling more than three months ago. A suggested stop-loss for PACS is $16.22, representing a 3.64% decrease from the current price.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   20 Nov 2025, 04:49 UTC

   The analyst published the original source item.

2. First prediction resolved

   20 Nov 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   20 Nov 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:13 UTC

   Tahlil Plus began monitoring the extracted predictions.